Research team uncovers new mechanisms of oxidative stress regulation

March 7, 2014 by Annie Deck-Miller

(Medical Xpress)—Regulation of oxidative stress is critical to cell survival. New preclinical research from Roswell Park Cancer Institute (RPCI) has revealed two key mechanisms by which oxidative stress is regulated in normal and cancerous cells.

Oxidative stress occurs when a cell is not able to adequately remove reactive oxygen species (ROS), or reactive molecules that result from the metabolism of oxygen. To alleviate these toxically high levels of ROS, cells activate NF-E2-related transcription factor 2 (Nrf2), which normally resides in the cytoplasm. Under conditions of , however, Nrf2 relocates to the nucleus, where it induces transcription of antioxidant genes.

For many years, ROS detoxification was considered the major function of Nrf2. Reciprocally, activation of Nrf2 was considered the major and universal mechanism for ROS detoxification.

Writing in the journal Molecular Cell, a team led by Mikhail Nikiforov, PhD, a Professor of Oncology and member of the Department of Cell Stress Biology at RPCI, has demonstrated that under certain conditions, Nrf2 behaves in ways that are directly opposite to its normal activities. These scientists have shown that if intracellular ROS exceed a critical threshold, Nrf2 induces expression of the transcription factor Klf9 (Kruppel-like factor 9), which in turn further increases ROS levels by suppressing cellular antioxidant genes, ultimately leading to cell death. The team verified this previously unrecognized feed-forward mechanism of ROS regulation in vivo using an animal model of idiopathic pulmonary fibrosis, a terminal disease of the lungs.

Reactive play a dual role in tumorigenesis. While low ROS levels promote tumor and increase genetic instability, high amounts of ROS are detrimental to cell proliferation or survival, inhibiting both healthy and diseased cells. The team's findings identify Klf9 as a molecular "switch" between the anti- and pro-oxidative functions of Nrf2.

"Tumor exhibit increased generation of as a consequence of high metabolic activity. Consequently, tumors often develop adaptive mechanisms to suppress high levels of ROS, so we looked for ways to exploit their weakness in the face of ROS increase," notes Dr. Nikiforov. "Our findings suggest that Klf9 depletion could be beneficial for malignancies where high amounts of ROS hinder tumor progression, including colorectal and gynecologic cancers. Our data may also support a role for Klf9 as a general tumor suppressor and provide further insights into the mechanism by which tumors acquire resistance to higher levels of ROS."

Activation of Klf9 may prove to be an effective complement to therapies that induce oxidative stress as a mechanism of cell killing, including cisplatinum, arsenic trioxide and the experimental agent elesclomol. Dr. Nikiforov and his team have begun subsequent studies to elucidate the role of Klf9 and its targets in tumor progression and drug resistance of several difficult-to-treat cancers, including melanoma and multiple myeloma.

This work has been supported in part by two National Institutes of Health (NIH) grants: awards R01CA120244, from the National Cancer Institute (NCI), and R01AI079253, from the National Institute of Allergy and Infectious Diseases (NIAID). Additional funds were provided by grant RSG-10-121-01 from the American Cancer Society (ACS).

The paper, "Nrf2 amplifies oxidative stress via induction of Klf9," was published online ahead of print today and can be accessed at cell.com/molecular-cell.

Explore further: Alcohol-breakdown molecule may play a role in breast cancer development

More information: Shoshanna N. Zucker, et al. "Nrf2 Amplifies Oxidative Stress via Induction of Klf9" Molecular Cell, 06 March, 2014 Elsevier, 10.1016/j.molcel.2014.01.033

Related Stories

Alcohol-breakdown molecule may play a role in breast cancer development

February 11, 2014
(Medical Xpress)—New research looking at the biological process involved in breast cancer development has strengthened the argument for a potential link between alcohol consumption and the disease.

Scientists identify new Huntington disease pathway

February 19, 2014
(Medical Xpress)—An international group of researchers has identified a major new pathway thought to be involved in the development of Huntington disease. The findings, published in the Proceedings of the National Academy ...

Nobel laureate publishes novel hypothesis on curing late-stage cancers

January 8, 2013
In a new paper he regards "among my most important work since the double helix," Nobelist James Watson sets forth a novel hypothesis regarding the role of oxidants and antioxidants in cancers that are currently incurable, ...

Researchers explain why some wound infections become chronic

December 17, 2013
Chronic wounds affect an estimated 6.5 million Americans at an annual cost of about $25 billion. Further, foot blisters and other diabetic ulcers or sores account for the vast majority of foot and leg amputations in the United ...

Two players produce destructive cascade of diabetic retinopathy

January 13, 2014
The retina can be bombarded by reactive oxygen species in diabetes, prompting events that destroy healthy blood vessels, form leaky new ones and ruin vision.

Recommended for you

Scientists develop blood test that spots tumor-derived DNA in people with early-stage cancers

August 16, 2017
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...

A metabolic treatment for pancreatic cancer?

August 15, 2017
Pancreatic cancer is now the third leading cause of cancer mortality. Its incidence is increasing in parallel with the population increase in obesity, and its five-year survival rate still hovers at just 8 to 9 percent. Research ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.